PREDICT-Meso endpoints school

by Alexandrea Macpherson | Mar 3, 2026 | NEWS, OUTPUTS

PREDICT-Meso is committed to training the next generation of mesothelioma researchers, and to share knowledge and best practice within the Network and beyond. To fulfill this commitment, PREDICT-Meso has run a series of training schools covering a range of topics...

PUBLICATION- Serum mesothelin as a response biomarker in pleural mesothelioma

by Alexandrea Macpherson | Jul 30, 2025 | NEWS, OUTPUTS

University of Bristol PhD researcher Dr Geraldine Lynch and the ASSESS-meso team have published results of their serum mesothelin (SM) research in the journal Lung Cancer. ‘Serum mesothelin as a response biomarker in pleural mesothelioma’ Free link to...

Publication – Current and future applications of artificial intelligence in lung cancer and mesothelioma

by Alexandrea Macpherson | Jun 24, 2025 | OUTPUTS

Newly published in Thorax, authors Joshua Roche, Farzaneh Seyedshahi, Kai Rakovic, Akari Win Thu, John Le Quesne and Kevin G Blyth disscuss Current and future applications of artificial intelligence in lung cancer and mesothelioma Free to access link:...

NEW PUBLICATION- Imaging in pleural Mesothelioma

by Alexandrea Macpherson | Jun 17, 2024 | NEWS, OUTPUTS

Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group Samuel G. Armato III, Sharyn I. Katz, Thomas Frauenfelder, Geeshath Jayasekera, Annamaria Catino, Kevin...

PUBLICATION- Leveraging the pleural space for anticancer therapies in pleural mesothelioma

by Alexandrea Macpherson | May 13, 2024 | NEWS, OUTPUTS

We urgently need new therapies #mesothelioma. Check out our new article in ⁦⁦@LancetRespirMed⁩ ‘Leveraging the pleural space for anticancer therapies in pleural mesothelioma’, which makes the case for expansion of intrapleural trials, covering who, why and...

Publication- Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells

by Alexandrea Macpherson | Jan 11, 2024 | NEWS, OUTPUTS

PREDICT-Meso Co-I Daniel J. Murphy co-authoured a paper accepted for publication in Cell Death and Disease, with Olivier E. Pardo and Yakinthi Chrisochoidou at Imperial. This work was carried out as part of WP4- Target Drug Validation Abstract Mesothelioma is an...